In vitro inhibitory effect of Nigella sativa L. extracts on SARS-COV-2 spike protein-ACE2 interaction

{ 'indexed': {'date-parts': [[2024, 9, 5]], 'date-time': '2024-09-05T00:33:37Z', 'timestamp': 1725496417468}, 'reference-count': 18, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2024, 8, 1]], 'date-time': '2024-08-01T00:00:00Z', 'timestamp': 1722470400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2024, 8, 1]], 'date-time': '2024-08-01T00:00:00Z', 'timestamp': 1722470400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/legal/tdmrep-license'}, { 'start': { 'date-parts': [[2024, 8, 20]], 'date-time': '2024-08-20T00:00:00Z', 'timestamp': 1724112000000}, 'content-version': 'vor', 'delay-in-days': 19, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 8]]}, 'DOI': '10.1016/j.curtheres.2024.100759', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 31]], 'date-time': '2024-08-31T02:26:20Z', 'timestamp': 1725071180000}, 'page': '100759', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'In vitro inhibitory effect of Nigella sativa L. extracts on SARS-COV-2 spike protein-ACE2 ' 'interaction.', 'prefix': '10.1016', 'author': [ {'given': 'Najma', 'family': 'Ali', 'sequence': 'first', 'affiliation': []}, {'given': 'Asha Caroline', 'family': 'Cyril', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anagha', 'family': 'P', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cijo George', 'family': 'Vazhappilly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Reem Kais', 'family': 'Jan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haneen', 'family': 'Aburamadan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fatemeh', 'family': 'Akbarpoor', 'sequence': 'additional', 'affiliation': []}, {'given': 'S M', 'family': 'Shariar Islam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fazilatun', 'family': 'Nessa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yosra', 'family': 'Lozon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Noushad', 'family': 'Karuvantevida', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rajan', 'family': 'Radhakrishnan', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '3', 'key': '10.1016/j.curtheres.2024.100759_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '1105', 'DOI': '10.1007/s00431-021-04306-6', 'article-title': 'Clinical spectrum of COVID-19 and risk factors associated with severity ' 'in Spanish children', 'volume': '181', 'author': 'Tagarro', 'year': '2022', 'journal-title': 'European Journal of Pediatrics'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '14214', 'DOI': '10.1038/s41598-020-71188-3', 'article-title': 'Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal ' 'unique mechanisms', 'volume': '10', 'author': 'Ali', 'year': '2020', 'journal-title': 'Scientific Reports'}, { 'issue': '4', 'key': '10.1016/j.curtheres.2024.100759_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '562', 'DOI': '10.1038/s41564-020-0688-y', 'article-title': 'Functional assessment of cell entry and receptor usage for SARS-CoV-2 ' 'and other lineage B betacoronaviruses', 'volume': '5', 'author': 'Letko', 'year': '2020', 'journal-title': 'Nature Microbiology'}, { 'issue': '2', 'key': '10.1016/j.curtheres.2024.100759_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/efd2.77', 'article-title': 'Dietary phytochemicals against COVID-19: A focus on thymoquinone', 'volume': '4', 'author': 'Li', 'year': '2023', 'journal-title': 'EFood'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1155/2020/2560645', 'article-title': 'Traditional Herbal Medicine Candidates as Complementary Treatments for ' 'COVID-19: A Review of Their Mechanisms, Pros and Cons', 'volume': '2020', 'author': 'Nugraha', 'year': '2020', 'journal-title': 'Evidence-Based Complementary and Alternative Medicine'}, { 'issue': '12', 'key': '10.1016/j.curtheres.2024.100759_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '4225', 'DOI': '10.1080/07391102.2020.1775129', 'article-title': 'Molecular docking, simulation and MM-PBSA studies of nigella sativa ' 'compounds: a computational quest to identify potential natural ' 'antiviral for COVID-19 treatment', 'volume': '39', 'author': 'Ahmad', 'year': '2021', 'journal-title': 'Journal of Biomolecular Structure and Dynamics'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '57', 'DOI': '10.1186/s42269-021-00517-x', 'article-title': 'In silico identification of compounds from Nigella sativa seed oil as ' 'potential inhibitors of SARS-CoV-2 targets', 'volume': '45', 'author': 'Duru', 'year': '2021', 'journal-title': 'Bulletin of the National Research Centre'}, { 'issue': '4', 'key': '10.1016/j.curtheres.2024.100759_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '682', 'DOI': '10.2174/0929867328666210420103021', 'article-title': 'SARS-CoV-2 Entry Inhibitors Targeting Virus-ACE2 or Virus-TMPRSS2 ' 'Interactions', 'volume': '29', 'author': 'Lin', 'year': '2022', 'journal-title': 'Current Medicinal Chemistry'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0009', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.vph.2021.106856', 'article-title': 'In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ' 'ACE1/2, AT1/2 to prevent COVID-19 induced ' 'vaso-tumult/vascular-damage/comorbidity', 'volume': '138', 'author': 'Maiti', 'year': '2021', 'journal-title': 'Vascular Pharmacology'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '483', 'DOI': '10.1007/s40121-021-00400-2', 'article-title': 'Computational and Experimental Studies Reveal That Thymoquinone Blocks ' 'the Entry of Coronaviruses Into In Vitro Cells', 'volume': '10', 'author': 'Xu', 'year': '2021', 'journal-title': 'Infectious Diseases and Therapy'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '618', 'DOI': '10.1186/s13063-021-05510-3', 'article-title': 'Prophylactic potential of honey and Nigella sativa L. against hospital ' 'and community-based SARS-CoV-2 spread: a structured summary of a study ' 'protocol for a randomised controlled trial', 'volume': '22', 'author': 'Ashraf', 'year': '2021', 'journal-title': 'Trials'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0012', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ctim.2021.102769', 'article-title': 'Nigella sativa for the treatment of COVID-19: An open-label randomized ' 'controlled clinical trial', 'volume': '61', 'author': 'Koshak', 'year': '2021', 'journal-title': 'Complementary Therapies in Medicine'}, { 'issue': '9', 'key': '10.1016/j.curtheres.2024.100759_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '2750', 'DOI': '10.3390/molecules27092750', 'article-title': 'Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical ' 'Constituents, Clinical Trials, Inventions, and Patent Literature', 'volume': '27', 'author': 'Imran', 'year': '2022', 'journal-title': 'Molecules'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1155/2023/8820543', 'article-title': 'Phytochemicals Analysis, In Vitro Antibacterial Activities of Extracts, ' 'and Molecular Docking Studies of the Isolated Compounds from Melhania ' 'zavattarii Cufod Leaves', 'volume': '2023', 'author': 'Gonfa', 'year': '2023', 'journal-title': 'Journal of Tropical Medicine'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '3', 'DOI': '10.1038/s41580-021-00418-x', 'article-title': 'Mechanisms of SARS-CoV-2 entry into cells', 'volume': '23', 'author': 'Jackson', 'year': '2022', 'journal-title': 'Nature Reviews. Molecular Cell Biology'}, { 'issue': '1', 'key': '10.1016/j.curtheres.2024.100759_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '694', 'DOI': '10.1080/13880209.2021.1931353', 'article-title': 'Possible therapeutic effects of Nigella sativa and its thymoquinone on ' 'COVID-19', 'volume': '59', 'author': 'Khazdair', 'year': '2021', 'journal-title': 'Pharmaceutical Biology'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0017', 'doi-asserted-by': 'crossref', 'DOI': '10.2139/ssrn.3612898', 'article-title': 'Rose and In-vitro Inhibition of SARS-CoV-2 spike: ACE-2 Interaction', 'author': 'Arokiaraj', 'year': '2020', 'journal-title': 'SSRN Electronic Journal'}, { 'key': '10.1016/j.curtheres.2024.100759_bib0018', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fchem.2021.638187', 'article-title': 'Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to ' 'Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral ' 'Drugs', 'volume': '9', 'author': 'Tito', 'year': '2021', 'journal-title': 'Frontiers in Chemistry'}], 'container-title': 'Current Therapeutic Research', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0011393X24000298?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0011393X24000298?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2024, 9, 4]], 'date-time': '2024-09-04T17:42:52Z', 'timestamp': 1725471772000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0011393X24000298'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 8]]}, 'references-count': 18, 'alternative-id': ['S0011393X24000298'], 'URL': 'http://dx.doi.org/10.1016/j.curtheres.2024.100759', 'relation': {}, 'ISSN': ['0011-393X'], 'subject': [], 'container-title-short': 'Current Therapeutic Research', 'published': {'date-parts': [[2024, 8]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'In vitro inhibitory effect of Nigella sativa L. extracts on SARS-COV-2 spike ' 'protein-ACE2 interaction.', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Current Therapeutic Research', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.curtheres.2024.100759', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2024 The Authors. Published by Elsevier Inc.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '100759'}